It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Making money online in 2023 presents new opportunities. Explore innovative methods to boost your income this year.
14,873 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
A viral episode claimed an AI-generated Monet fooled millions, but the artwork was genuine. The episode underscores h...
Rural homebuyers face a competitive market, but USDA loans offer zero-down options. This report identifies the top le...
A large investment pledge could reshape U.S. energy markets. This article explains what to watch and highlights two s...
A 40-year-old who is recently divorced can still reach a comfortable retirement if they commit to disciplined saving ...
Wall Street is piling into hydration brands as 'functional hydration' takes hold. The trend follows social media chat...
A moment at Paris Fashion Week turned into a financial lesson for readers worldwide. This article breaks down how a v...
IBM's Justina Nixon-Saintil oversees a sweeping retraining drive aimed at 30 million workers by 2030, signaling a shi...
Hasbro stock jumped today after a stronger quarter and higher guidance. This guide explains the earnings drivers, wha...
Cloud giants and AI pioneers are driving a wave of data-center investment. We break down three stock picks that could...
Gas prices near $4 per gallon are forcing households to recalibrate routines, even as overall spending remains resili...